ArticleUnited European gastroenterology journal2015
A phase II study of TRC105 in patients with hepatocellular carcinoma who have progressed on sorafenib.
A G Duffy et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
32 papers cite it
this papertrialcites it